• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖化血红蛋白指数是成年人全因死亡率和心血管死亡率的新预测指标。

Glycated haemoglobin index is a new predictor for all-cause mortality and cardiovascular mortality in the adults.

机构信息

School of Pharmacy, Jiangxi University of Traditional Chinese Medicine, Nanchang, Jiangxi, China.

Department of Cardiovascular Medicine, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, China.

出版信息

Sci Rep. 2024 Aug 23;14(1):19629. doi: 10.1038/s41598-024-70666-2.

DOI:10.1038/s41598-024-70666-2
PMID:39179628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11343730/
Abstract

Glycosylated haemoglobin index (HGI) has been shown to correlate with the prognosis of metabolic diseases, but the relationship with mortality remains unclear. This study included 18,285 US adults who participated in the National Health and Nutrition Examination Survey (NHANES) between 1999 and 2018. During the median follow-up period of 115 months, a total of 2572 all-cause deaths and 671 cardiovascular disease (CVD) deaths occurred. The restricted cubic spline revealed a U-shaped correlation between HGI and all-cause and CVD mortality. After adjusting for all covariates, the optimal inflection point values in all-cause and CVD deaths were 0.17 and 0.02, respectively. In the left side of the inflection point, the risk of all-cause mortality and CVD mortality decreased by approximately 24% (HR 0.76, 95% CI 0.69, 0.84) and 25% (HR 0.75, 95% CI 0.60, 0.96) with the increase in HGI. Conversely, in the right of the inflection point, an increase of 1 unit in the HGI was linked with a 17% (HR 1.17, 95% CI 1.07, 1.27) and 31% (HR 1.31, 95% CI 1.15, 1.49) increase in all-cause and CVD mortality. Our study showed that HGI is an important tool for predicting the risk of all-cause mortality and CVD death in US adults and there is a U-shaped relationship between HGI and mortality.

摘要

糖化血红蛋白指数 (HGI) 已被证明与代谢性疾病的预后相关,但与死亡率的关系尚不清楚。本研究纳入了 1999 年至 2018 年期间参加美国国家健康和营养调查 (NHANES) 的 18285 名美国成年人。在中位数为 115 个月的随访期间,共有 2572 例全因死亡和 671 例心血管疾病 (CVD) 死亡。限制三次样条显示 HGI 与全因和 CVD 死亡率之间呈 U 形相关。在调整了所有协变量后,全因和 CVD 死亡的最佳拐点值分别为 0.17 和 0.02。在拐点的左侧,全因死亡率和 CVD 死亡率的风险分别降低了约 24%(HR 0.76,95%CI 0.69,0.84)和 25%(HR 0.75,95%CI 0.60,0.96),HGI 增加。相反,在拐点的右侧,HGI 增加 1 个单位与全因死亡率和 CVD 死亡率分别增加 17%(HR 1.17,95%CI 1.07,1.27)和 31%(HR 1.31,95%CI 1.15,1.49)相关。我们的研究表明,HGI 是预测美国成年人全因死亡率和 CVD 死亡风险的重要工具,HGI 与死亡率之间呈 U 形关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dba/11343730/49ecef80c49c/41598_2024_70666_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dba/11343730/bfe3851cc928/41598_2024_70666_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dba/11343730/044e898e30a6/41598_2024_70666_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dba/11343730/49ecef80c49c/41598_2024_70666_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dba/11343730/bfe3851cc928/41598_2024_70666_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dba/11343730/044e898e30a6/41598_2024_70666_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dba/11343730/49ecef80c49c/41598_2024_70666_Fig3_HTML.jpg

相似文献

1
Glycated haemoglobin index is a new predictor for all-cause mortality and cardiovascular mortality in the adults.糖化血红蛋白指数是成年人全因死亡率和心血管死亡率的新预测指标。
Sci Rep. 2024 Aug 23;14(1):19629. doi: 10.1038/s41598-024-70666-2.
2
Sex-specific associations between haemoglobin glycation index and the risk of cardiovascular and all-cause mortality in individuals with pre-diabetes and diabetes: A large prospective cohort study.糖化血红蛋白指数与糖尿病前期和糖尿病患者心血管和全因死亡率风险的性别特异性关联:一项大型前瞻性队列研究。
Diabetes Obes Metab. 2024 Jun;26(6):2275-2283. doi: 10.1111/dom.15541. Epub 2024 Mar 7.
3
Association of the hemoglobin glycation index with cardiovascular and all-cause mortality in individuals with hypertension: findings from NHANES 1999-2018.血红蛋白糖化指数与高血压个体心血管和全因死亡率的关联:来自 NHANES 1999-2018 的研究结果。
Front Endocrinol (Lausanne). 2024 Jun 10;15:1401317. doi: 10.3389/fendo.2024.1401317. eCollection 2024.
4
Association of haemoglobin glycation index with all-cause and cardiovascular disease mortality in diabetic kidney disease: a cohort study.糖尿病肾病中血红蛋白糖化指数与全因死亡率和心血管疾病死亡率的关联:一项队列研究
Diabetol Metab Syndr. 2024 Sep 11;16(1):221. doi: 10.1186/s13098-024-01462-1.
5
Serum uric acid to high-density lipoprotein cholesterol ratio is a predictor for all-cause and cardiovascular disease mortality in patients with diabetes: Evidence from NHANES 2005-2018.血尿酸与高密度脂蛋白胆固醇比值是预测糖尿病患者全因和心血管疾病死亡率的指标:来自 NHANES 2005-2018 的证据。
Nutr Metab Cardiovasc Dis. 2024 Nov;34(11):2480-2488. doi: 10.1016/j.numecd.2024.07.001. Epub 2024 Jul 14.
6
The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) as a predictor of all-cause and cardiovascular mortality in US adults with diabetes or prediabetes: NHANES 1999-2018.非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值(NHHR)作为美国糖尿病或糖尿病前期成年人全因死亡率和心血管死亡率的预测指标:1999 - 2018年美国国家健康与营养检查调查(NHANES)
BMC Med. 2024 Aug 7;22(1):317. doi: 10.1186/s12916-024-03536-3.
7
Metabolic score for insulin resistance (METS-IR) predicts all-cause and cardiovascular mortality in the general population: evidence from NHANES 2001-2018.代谢性胰岛素抵抗评分(METS-IR)可预测普通人群的全因和心血管死亡率:来自 NHANES 2001-2018 的证据。
Cardiovasc Diabetol. 2024 Jul 10;23(1):243. doi: 10.1186/s12933-024-02334-8.
8
Association between the triglyceride-glucose index and all-cause and CVD mortality in the young population with diabetes.甘油三酯-葡萄糖指数与糖尿病青年人群全因和 CVD 死亡率的关系。
Cardiovasc Diabetol. 2024 May 16;23(1):171. doi: 10.1186/s12933-024-02269-0.
9
Association of triglyceride glucose-related parameters with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999-2018.NAFLD 患者甘油三酯-葡萄糖相关参数与全因死亡率和心血管疾病的关系:NHANES 1999-2018。
Cardiovasc Diabetol. 2024 Jul 18;23(1):262. doi: 10.1186/s12933-024-02354-4.
10
Association between advanced lung cancer inflammation index and all-cause and cardiovascular mortality among stroke patients: NHANES, 1999-2018.1999 - 2018年美国国家健康与营养检查调查(NHANES):中风患者中晚期肺癌炎症指数与全因死亡率和心血管死亡率之间的关联
Front Public Health. 2024 Apr 18;12:1370322. doi: 10.3389/fpubh.2024.1370322. eCollection 2024.

引用本文的文献

1
Association of Hemoglobin Glycation Index With All-Cause Mortality, Cardiac Mortality, and Cardiovascular Mortality in the General Population: A Retrospective Cohort Study of NHANES Data.糖化血红蛋白指数与一般人群全因死亡率、心脏死亡率和心血管死亡率的关联:基于美国国家健康与营养检查调查(NHANES)数据的回顾性队列研究
Rev Cardiovasc Med. 2025 Jul 28;26(7):36792. doi: 10.31083/RCM36792. eCollection 2025 Jul.
2
Delving into biomarkers and predictive modeling for CVD mortality: a 20-year cohort study.深入研究心血管疾病死亡率的生物标志物和预测模型:一项为期20年的队列研究。
Sci Rep. 2025 Feb 3;15(1):4134. doi: 10.1038/s41598-025-88790-y.

本文引用的文献

1
Hypoglycemia and Cardiovascular Disease: Exploring the Connections.低血糖与心血管疾病:探寻两者之间的联系
Cureus. 2023 Oct 27;15(10):e47784. doi: 10.7759/cureus.47784. eCollection 2023 Oct.
2
Association between hemoglobin glycation index and non-alcoholic fatty liver disease in the patients with type 2 diabetes mellitus.糖化血红蛋白指数与 2 型糖尿病患者非酒精性脂肪肝的相关性。
J Diabetes Investig. 2023 Nov;14(11):1303-1311. doi: 10.1111/jdi.14066. Epub 2023 Aug 8.
3
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
2023 年 AHA/ACC/ACCP/ASPC/NLA/PCNA 慢性冠状动脉疾病患者管理指南:美国心脏协会/美国心脏病学会联合临床实践指南委员会的报告。
Circulation. 2023 Aug 29;148(9):e9-e119. doi: 10.1161/CIR.0000000000001168. Epub 2023 Jul 20.
4
Association between hemoglobin glycation index and 5-year major adverse cardiovascular events: the REACTION cohort study.糖化血红蛋白指数与 5 年主要不良心血管事件的关联:REACTION 队列研究。
Chin Med J (Engl). 2023 Oct 20;136(20):2468-2475. doi: 10.1097/CM9.0000000000002717. Epub 2023 Jun 2.
5
Association Between Hemoglobin Glycation Index and Metabolic Syndrome in Middle-Aged and Older People.中老年人群糖化血红蛋白指数与代谢综合征之间的关联
Diabetes Metab Syndr Obes. 2023 May 19;16:1471-1479. doi: 10.2147/DMSO.S406660. eCollection 2023.
6
Correlation Between Hemoglobin Glycation Index Measured by Continuous Glucose Monitoring With Complications in Type 1 Diabetes.通过持续葡萄糖监测测定的血红蛋白糖化指数与1型糖尿病并发症之间的相关性
Endocr Pract. 2023 Mar;29(3):162-167. doi: 10.1016/j.eprac.2023.01.001. Epub 2023 Jan 7.
7
Interaction of sex and diabetes on the association between hemoglobin glycation index, hemoglobin A1c and serum uric acid.性别与糖尿病在糖化血红蛋白指数、糖化血红蛋白A1c与血清尿酸之间关联上的相互作用。
Diabetol Metab Syndr. 2022 Dec 4;14(1):185. doi: 10.1186/s13098-022-00955-1.
8
Association of hemoglobin glycation index with cardiovascular risk factors in non-diabetic adults: A cross-sectional study.糖化血红蛋白指数与非糖尿病成年人心血管危险因素的相关性:一项横断面研究。
Diabetes Metab Syndr. 2022 Sep;16(9):102592. doi: 10.1016/j.dsx.2022.102592. Epub 2022 Aug 15.
9
Stress hyperglycemia ratio and long-term mortality after acute myocardial infarction in patients with and without diabetes: A prospective, nationwide, and multicentre registry.应激性高血糖比值与合并或不合并糖尿病的急性心肌梗死患者的长期死亡率:一项前瞻性、全国性、多中心注册研究。
Diabetes Metab Res Rev. 2022 Oct;38(7):e3562. doi: 10.1002/dmrr.3562. Epub 2022 Jul 13.
10
Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association.《心脏病与卒中统计-2022 更新:美国心脏协会报告》。
Circulation. 2022 Feb 22;145(8):e153-e639. doi: 10.1161/CIR.0000000000001052. Epub 2022 Jan 26.